Ostéoporose pendant la ménopause

Area of Science:

• Obstetrics and Gynecology
• Endocrinology
• Gerontology

Background:

• Postmenopausal osteoporosis is a significant health concern, increasing fracture risk in women.
• Early identification and management are crucial for preventing debilitating bone loss.
• Current guidelines require updates to reflect the latest research and clinical evidence.

Purpose of the Study:

• To provide healthcare providers with comprehensive guidelines for the prevention, diagnosis, and clinical management of postmenopausal osteoporosis.
• To outline strategies for identifying and assessing high-risk women.
• To recommend interventions including bone mineral density testing, lifestyle modifications, and pharmacotherapy.

Main Methods:

• Systematic literature review of MEDLINE and The Cochrane Library up to March 2013.
• Inclusion of systematic reviews, randomized controlled trials, and observational studies published in English or French from 2009 onwards.
• Inclusion of grey literature from health technology assessment agencies and professional societies.

Main Results:

• Identified key strategies for risk assessment and diagnosis of postmenopausal osteoporosis.
• Evaluated the role of bone mineral density and bone turnover markers in diagnosis and management response.
• Summarized evidence-based recommendations for nutrition, physical activity, and pharmacologic treatments.

Conclusions:

• The guideline offers evidence-based recommendations for optimizing postmenopausal osteoporosis care.
• It aims to reduce fracture incidence and improve bone health in postmenopausal women.
• Adherence to these guidelines can lead to improved patient outcomes and quality of life.